We've found
14,731
archived clinical trials in
Psychiatric
We've found
14,731
archived clinical trials in
Psychiatric
Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment
Updated: 4/12/2018
Randomized Double-Blind Placebo Controlled Study of Testosterone in the Adjuvant Treatment of Postmenopausal Women With Aromatase Inhibitor Induced Arthralgias
Status: Enrolling
Updated: 4/12/2018
Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment
Updated: 4/12/2018
Randomized Double-Blind Placebo Controlled Study of Testosterone in the Adjuvant Treatment of Postmenopausal Women With Aromatase Inhibitor Induced Arthralgias
Status: Enrolling
Updated: 4/12/2018
Click here to add this to my saved trials
STimulation to Improve Auditory haLLucinations
Updated: 4/15/2018
Targeting Auditory Hallucinations With Alternating Current Stimulation
Status: Enrolling
Updated: 4/15/2018
STimulation to Improve Auditory haLLucinations
Updated: 4/15/2018
Targeting Auditory Hallucinations With Alternating Current Stimulation
Status: Enrolling
Updated: 4/15/2018
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
A Trial of CM-AT in Children With Autism
Updated: 4/17/2018
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
Primary Care Brief Mindfulness Training for Veterans With PTSD
Updated: 4/17/2018
Primary Care Brief Mindfulness Training for Veterans With PTSD
Status: Enrolling
Updated: 4/17/2018
Primary Care Brief Mindfulness Training for Veterans With PTSD
Updated: 4/17/2018
Primary Care Brief Mindfulness Training for Veterans With PTSD
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
Stepped Care Treatment for Binge-Eating
Updated: 4/18/2018
Dialectical Behavior Therapy for Early Non-Responders to CBT
Status: Enrolling
Updated: 4/18/2018
Stepped Care Treatment for Binge-Eating
Updated: 4/18/2018
Dialectical Behavior Therapy for Early Non-Responders to CBT
Status: Enrolling
Updated: 4/18/2018
Click here to add this to my saved trials
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
Updated: 4/19/2018
A Randomized Trial of an Abstinence-reinforcing Contingency Management Intervention to Suppress HIV Viral Load
Status: Enrolling
Updated: 4/19/2018
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
Updated: 4/19/2018
A Randomized Trial of an Abstinence-reinforcing Contingency Management Intervention to Suppress HIV Viral Load
Status: Enrolling
Updated: 4/19/2018
Click here to add this to my saved trials
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
Updated: 4/19/2018
A Randomized Trial of an Abstinence-reinforcing Contingency Management Intervention to Suppress HIV Viral Load
Status: Enrolling
Updated: 4/19/2018
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
Updated: 4/19/2018
A Randomized Trial of an Abstinence-reinforcing Contingency Management Intervention to Suppress HIV Viral Load
Status: Enrolling
Updated: 4/19/2018
Click here to add this to my saved trials
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
Updated: 4/19/2018
A Randomized Trial of an Abstinence-reinforcing Contingency Management Intervention to Suppress HIV Viral Load
Status: Enrolling
Updated: 4/19/2018
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
Updated: 4/19/2018
A Randomized Trial of an Abstinence-reinforcing Contingency Management Intervention to Suppress HIV Viral Load
Status: Enrolling
Updated: 4/19/2018
Click here to add this to my saved trials
Pilot Test of a Community-based Buprenorphine Treatment Intervention
Updated: 4/19/2018
Development of a Community-based Buprenorphine Treatment Intervention
Status: Enrolling
Updated: 4/19/2018
Pilot Test of a Community-based Buprenorphine Treatment Intervention
Updated: 4/19/2018
Development of a Community-based Buprenorphine Treatment Intervention
Status: Enrolling
Updated: 4/19/2018
Click here to add this to my saved trials
Evaluation of an Entrepreneurship Program for American-Indian Youth
Updated: 4/19/2018
Evaluation of an Entrepreneurship Program on Psychosocial, Behavioral Health, Educational and Economic Outcomes Among American-Indian Youth
Status: Enrolling
Updated: 4/19/2018
Evaluation of an Entrepreneurship Program for American-Indian Youth
Updated: 4/19/2018
Evaluation of an Entrepreneurship Program on Psychosocial, Behavioral Health, Educational and Economic Outcomes Among American-Indian Youth
Status: Enrolling
Updated: 4/19/2018
Click here to add this to my saved trials
Effectiveness of PTSD Treatment For Suicidal and Multi-Diagnostic Clients
Updated: 4/19/2018
Effectiveness of PTSD Treatment For Suicidal and Multi-Diagnostic Clients
Status: Enrolling
Updated: 4/19/2018
Effectiveness of PTSD Treatment For Suicidal and Multi-Diagnostic Clients
Updated: 4/19/2018
Effectiveness of PTSD Treatment For Suicidal and Multi-Diagnostic Clients
Status: Enrolling
Updated: 4/19/2018
Click here to add this to my saved trials
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
Updated: 4/20/2018
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
Status: Enrolling
Updated: 4/20/2018
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
Updated: 4/20/2018
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
Status: Enrolling
Updated: 4/20/2018
Click here to add this to my saved trials
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
Updated: 4/20/2018
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
Status: Enrolling
Updated: 4/20/2018
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
Updated: 4/20/2018
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
Status: Enrolling
Updated: 4/20/2018
Click here to add this to my saved trials
Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder
Updated: 4/20/2018
Interventional, Randomised, Double-blind, Parallel-group, Active-control, Multiple-dose Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder
Status: Enrolling
Updated: 4/20/2018
Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder
Updated: 4/20/2018
Interventional, Randomised, Double-blind, Parallel-group, Active-control, Multiple-dose Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder
Status: Enrolling
Updated: 4/20/2018
Click here to add this to my saved trials
Psychological Symptom Change in Veterans After Six Sessions of EFT (Emotional Freedom Techniques)
Updated: 4/23/2018
Psychological Symptom Change in Veterans After Six Sessions of EFT (Emotional Freedom Techniques): A Randomized Controlled Trial
Status: Enrolling
Updated: 4/23/2018
Psychological Symptom Change in Veterans After Six Sessions of EFT (Emotional Freedom Techniques)
Updated: 4/23/2018
Psychological Symptom Change in Veterans After Six Sessions of EFT (Emotional Freedom Techniques): A Randomized Controlled Trial
Status: Enrolling
Updated: 4/23/2018
Click here to add this to my saved trials
Gene Expression Correlates of Post-Traumatic Stress Disorder (PTSD) Symptom Change After EFT (Emotional Freedom Techniques)
Updated: 4/23/2018
Gene Expression Correlates of PTSD Symptom Change After EFT (Emotional Freedom Techniques): A Randomized Controlled Trial
Status: Enrolling
Updated: 4/23/2018
Gene Expression Correlates of Post-Traumatic Stress Disorder (PTSD) Symptom Change After EFT (Emotional Freedom Techniques)
Updated: 4/23/2018
Gene Expression Correlates of PTSD Symptom Change After EFT (Emotional Freedom Techniques): A Randomized Controlled Trial
Status: Enrolling
Updated: 4/23/2018
Click here to add this to my saved trials
An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
Updated: 4/23/2018
An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
Status: Enrolling
Updated: 4/23/2018
An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
Updated: 4/23/2018
An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
Status: Enrolling
Updated: 4/23/2018
Click here to add this to my saved trials
Pilot Study of Virtual Reality for Providing Exposure Therapy to Children
Updated: 4/23/2018
Low-Cost, Virtual Reality System to Increase Access to Exposure Therapy for Anxiety and Obsessive Compulsive Disorders
Status: Enrolling
Updated: 4/23/2018
Pilot Study of Virtual Reality for Providing Exposure Therapy to Children
Updated: 4/23/2018
Low-Cost, Virtual Reality System to Increase Access to Exposure Therapy for Anxiety and Obsessive Compulsive Disorders
Status: Enrolling
Updated: 4/23/2018
Click here to add this to my saved trials
The Effect of EFT on Psychological States in a Veterans Population
Updated: 4/23/2018
The Effect of EFT (Emotional Freedom Techniques) on Psychological States in a Veterans Population: A Randomized Controlled Trial
Status: Enrolling
Updated: 4/23/2018
The Effect of EFT on Psychological States in a Veterans Population
Updated: 4/23/2018
The Effect of EFT (Emotional Freedom Techniques) on Psychological States in a Veterans Population: A Randomized Controlled Trial
Status: Enrolling
Updated: 4/23/2018
Click here to add this to my saved trials
Phenotypic and Genetic Factors in Autism Spectrum Disorders
Updated: 4/25/2018
Phenotypic and Genetic Factors in Autism Spectrum Disorders
Status: Enrolling
Updated: 4/25/2018
Phenotypic and Genetic Factors in Autism Spectrum Disorders
Updated: 4/25/2018
Phenotypic and Genetic Factors in Autism Spectrum Disorders
Status: Enrolling
Updated: 4/25/2018
Click here to add this to my saved trials
Evaluation of ProVetus/Sponsorship Initiative
Updated: 4/26/2018
Evaluation of ProVetus/Sponsorship Initiative
Status: Enrolling
Updated: 4/26/2018
Evaluation of ProVetus/Sponsorship Initiative
Updated: 4/26/2018
Evaluation of ProVetus/Sponsorship Initiative
Status: Enrolling
Updated: 4/26/2018
Click here to add this to my saved trials
Sapropterin as a Treatment for Autistic Disorder
Updated: 4/27/2018
Sapropterin as a Treatment for Autistic Disorder: A Phase II Randomized, Double-Blind, Placebo-Controlled Trial
Status: Enrolling
Updated: 4/27/2018
Sapropterin as a Treatment for Autistic Disorder
Updated: 4/27/2018
Sapropterin as a Treatment for Autistic Disorder: A Phase II Randomized, Double-Blind, Placebo-Controlled Trial
Status: Enrolling
Updated: 4/27/2018
Click here to add this to my saved trials
College Health Center-based Alcohol and Sexual Violence Intervention
Updated: 4/27/2018
GIFTSS (Giving Information for Trauma Support and Safety): A College Health Center-based Alcohol and Sexual Violence Intervention
Status: Enrolling
Updated: 4/27/2018
College Health Center-based Alcohol and Sexual Violence Intervention
Updated: 4/27/2018
GIFTSS (Giving Information for Trauma Support and Safety): A College Health Center-based Alcohol and Sexual Violence Intervention
Status: Enrolling
Updated: 4/27/2018
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
Updated: 4/27/2018
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
Updated: 4/27/2018
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
Updated: 4/27/2018
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
Updated: 4/27/2018
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
Updated: 4/27/2018
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
Updated: 4/27/2018
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
Updated: 4/27/2018
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
Updated: 4/27/2018
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
Updated: 4/27/2018
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
Updated: 4/27/2018
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
Updated: 4/27/2018
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
Updated: 4/27/2018
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
Updated: 4/27/2018
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
Updated: 4/27/2018
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
Updated: 4/27/2018
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
Updated: 4/27/2018
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
Updated: 4/27/2018
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
Updated: 4/27/2018
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Click here to add this to my saved trials